MILLICENT PHARMA (NI) LIMITED
Get an alert when MILLICENT PHARMA (NI) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£37K
-31.5% vs 2023
Net assets
£1.3M
-6.3% vs 2023
Employees
31
+3.3% vs 2023
Profit before tax
-£11K
-118.6% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £2,482,000 | £3,558,000 | +43.4% | |
| Operating profit | £113,000 | £22,000 | -80.5% | |
| Profit before tax | £59,000 | -£11,000 | -118.6% | |
| Net profit | -£40,000 | -£89,000 | -122.5% | |
| Cash | £54,000 | £37,000 | -31.5% | |
| Total assets less current liabilities | £1,407,000 | £1,318,000 | -6.3% | |
| Net assets | £1,407,000 | £1,318,000 | -6.3% | |
| Equity | £1,407,000 | £1,318,000 | -6.3% | |
| Average employees | 30 | 31 | +3.3% | |
| Wages | £1,196,000 | £1,229,000 | +2.8% | |
| Directors' remuneration | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 4.6% | 0.6% | |
| Net margin | -1.6% | -2.5% | |
| Return on capital employed | 8.0% | 1.7% | |
| Current ratio | 0.84x | 0.89x | |
| Interest cover | 2.09x | 0.67x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. The Company meets its day-to-day working capital requirements through its bank facilities and intercompany funding made available through other companies within the group. The Company's forecasts and projections, taking account of reasonably possible changes in trading performance, show that the company and other companies within the group should be able to operate within the level of its current facilities. The director has a reasonable expectation that the company, and companies with which it trades, have adequate resources to continue in operational existence for the foreseeable future.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LOUGHLIN, Ryan Gerald, Dr | Director | 2022-02-21 | Sep 1981 | Irish |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JACKSON, Anthony John David, Dr | Director | 2018-06-07 | 2021-03-01 |
| MCILROY, James William, Dr | Director | 2021-03-01 | 2022-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Millicent Pharma Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, Significant influence (as firm) | 2018-06-07 | Ceased 2018-06-07 |
Filing timeline
Last 20 of 26 total filings
Material constitutional events — rename, articles re-file, resolution
- 2020-01-08 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-30 | AA | accounts | Accounts with accounts type full | |
| 2025-05-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-15 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2025-03-25 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-08-21 | AA | accounts | Accounts with accounts type full | |
| 2024-05-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-06 | AA | accounts | Accounts with accounts type full | |
| 2023-06-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-30 | AA | accounts | Accounts with accounts type full | |
| 2022-06-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-15 | TM01 | officers | Termination director company with name termination date | |
| 2022-02-21 | AP01 | officers | Appoint person director company with name date | |
| 2021-08-17 | AA | accounts | Accounts with accounts type full | |
| 2021-06-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-03-15 | TM01 | officers | Termination director company with name termination date | |
| 2021-03-15 | AP01 | officers | Appoint person director company with name date | |
| 2020-10-15 | AA | accounts | Accounts with accounts type full | |
| 2020-06-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2020-01-08 | SH01 | capital | Capital allotment shares | |
| 2020-01-08 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.